Objective: To explore Influencing factors of hospitalization costs in adult patients with bronchiectasis. Methods: The data were collected from public hospitals in China between May 2016 and December 2019, the information collected includes the following: total hospitalization cost, age, sex, blood routine, length of stay, and complications. Result: A total of 462 effective cases were collected in this study, including 234 males (50.65%) and 228 females (49.35%). In hospitalization costs, single total hospitalization cost is 13610.87 yuan per capita, among them the quartile is 7453.50 yuan, the median is 9893.51 yuan, upper quartile is 14153.62 yuan. Base on the proportion of hospitalization costs in adult patients with bronchiectasis, the drug cost was the highest (40.53%), the test cost was the second (20.59), and the nursing cost was the lowest (2.59%). In results of univariate analysis of cases with different characteristics, chronic obstructive pulmonary disease (COPD), smoking history, age, duration of hospitalization, and the percentage of neutrophils were statistical significance (p < 0.05). independent factors. Conclusion: independent factors of hospitalization costs in adult patients with bronchiectasis included hospitalization duration, smoking history, COPD, and high neutrophil percentage. Therefore, medical staffs should control and avoid those factors in treatment of adult patients with bronchiectasis.
Published in | American Journal of Nursing Science (Volume 10, Issue 1) |
DOI | 10.11648/j.ajns.20211001.26 |
Page(s) | 86-90 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Bronchiectasis, Hospitalization Costs, Complications
[1] | Cai BQ, He QY, Gao ZC, et al. Expert consensus on the diagnosis and treatment of adult bronchiectasis (2012 Edition). Chinese Journal of Critical Care Medicine (Electronic). 2012; 5 (05): 315-328. |
[2] | Tian CY, Gao Y. Statistical analysis of disease and death of respiratory and critically ill patients in a hospital. Chinese Medical Record. 2020; 21 (01): 64-66. |
[3] | Zhang YQ. Investigation on the disease composition of inpatients in respiratory department of a third-class A hospital in Liaoning from 2012 to 2016. Chinese Medical Record. 2018; 19 (11): 48-51. |
[4] | Weycker D, Hansen GL, Seifer FD. Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013. Chron Respir Dis. 2017; 14 (4): 377-384. |
[5] | King P. The pathophysiology of bronchiectasis, Int. J. Chronic Obstr. Pulm. Dis. 2019; 4: 411–419. |
[6] | Zhou YM, Wang C, Yao WZ, et al. Investigation on the prevalence and risk factors of bronchiectasis among residents aged 40 and older in 7 provinces and cities in China [J]. Chinese Journal of Internal Medicine. 2013; 52 (5): 379-382. |
[7] | De La Rosa D, Martinez-Garcia M A, Olveira C, et al. Annual direct medical costs of bronchiectasis treatment: Impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistence. Chron Respir Dis. 2016; 13 (4): 361-371. |
[8] | Goeminne P C, Hernandez F, Diel R, et al. The economic burden of bronchiectasis - known and unknown: a systematic review. BMC Pulm Med. 2019; 19 (1): 54. |
[9] | Polverino E, Goeminne PC, Mcdonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. The European respiratory journal. 2017; 50 (3): 1700629. |
[10] | Li CX, Han MF, Zhou XP, et al. Study on the distribution of pathogenic bacteria in patients with bronchiectasis associated with infection and direct economic loss caused by drug resistance. Journal of Clinical Pulmonary Surgery. 2018; 23 (09): 1680-1683. |
[11] | Nakajima T, Yoshino I. Massive Hemoptysis; Clinical Approach and Surgical Treatment. Kyobu Geka. 2015; 68 (8): 665-670. |
[12] | Liu B, Zhou RQ, Xing QF. Analysis of risk factors of elderly COPD complicated with bronchiectasis. Chinese Journal of Lung Diseases (Electronic Edition). 2019; 12 (03): 301-305. |
[13] | Sanchez-Munoz G, Lopez De Andres A, Jimenez-Garcia R, et al. Time Trends in Hospital Admissions for Bronchiectasis: Analysis of the Spanish National Hospital Discharge Data (2004 to 2013). PLoS One. 2016; 11 (9): e0162282. |
[14] | Xu X. Risk factors of COPD in middle-aged and elderly smoking population in rural areas. Practical Preventive Medicine. 2014; 21 (03): 376-378. |
[15] | Xu J. Effect of smoking on pulmonary function and airway inflammatory response in patients with emphysema. Chinese Journal of Experimental Diagnostics. 2016; 20 (08): 1302-1304. |
[16] | Wang F, Zhou YP, Xia JJ, et al. The relationship between smoking and pulmonary structure changes in patients with chronic obstructive pulmonary disease. Clin Pulmonol. 2018; 23 (01): 17-20. |
[17] | Zou Y, Chen X, He B, et al. Neutrophil extracellular traps induced by cigarette smoke contribute to airway inflammation in mice [J]. Exp Cell Res. 2020: 111888. |
[18] | Dou S, Zheng C, Cui L, et al. High prevalence of bronchiectasis in emphysema-predominant COPD patients. Int J Chron Obstruct Pulmon Dis. 2018; 13: 2041-2047. |
[19] | Cui JJ. Etiological analysis of 92 patients with bronchiectasis and its relationship with disease severity. 2017. |
[20] | Chalmers J D, Aliberti S, Filonenko A, et al. Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis. Am J Respir Crit Care Med. 2018; 197 (11): 1410-1420. |
[21] | Martinez-Garcia M A, Miravitlles M. Bronchiectasis in COPD patients: more than a comorbidity?. Int J Chron Obstruct Pulmon Dis. 2017; 12: 1401-1411. |
[22] | Sanchez-Munoz G, Lopez-De-Andres A, Hernandez-Barrera V, et al. Bronchiectasis in patients hospitalized with acute exacerbation of COPD in Spain: Influence on mortality, hospital stay, and hospital costs (2006-2014) according to gender. PLoS One. 2019; 14 (1): e0211222. |
[23] | Bedi P, Davidson D J, Mchugh B J, et al. Blood Neutrophils Are Reprogrammed in Bronchiectasis. American journal of respiratory and critical care medicine. 2018; 198 (7): 880-890. |
[24] | Drost N, D'silva L, Rebello R, et al. Persistent sputum cellularity and neutrophils may predict bronchiectasis. Can Respir J. 2011, 18 (4): 221-224. |
APA Style
Yanxiu Lei, Lineng Zhou, Yanli Yang, Ting Li. (2021). Influencing Factors of Hospitalization Costs in Adult Patients with Bronchiectasis. American Journal of Nursing Science, 10(1), 86-90. https://doi.org/10.11648/j.ajns.20211001.26
ACS Style
Yanxiu Lei; Lineng Zhou; Yanli Yang; Ting Li. Influencing Factors of Hospitalization Costs in Adult Patients with Bronchiectasis. Am. J. Nurs. Sci. 2021, 10(1), 86-90. doi: 10.11648/j.ajns.20211001.26
AMA Style
Yanxiu Lei, Lineng Zhou, Yanli Yang, Ting Li. Influencing Factors of Hospitalization Costs in Adult Patients with Bronchiectasis. Am J Nurs Sci. 2021;10(1):86-90. doi: 10.11648/j.ajns.20211001.26
@article{10.11648/j.ajns.20211001.26, author = {Yanxiu Lei and Lineng Zhou and Yanli Yang and Ting Li}, title = {Influencing Factors of Hospitalization Costs in Adult Patients with Bronchiectasis}, journal = {American Journal of Nursing Science}, volume = {10}, number = {1}, pages = {86-90}, doi = {10.11648/j.ajns.20211001.26}, url = {https://doi.org/10.11648/j.ajns.20211001.26}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajns.20211001.26}, abstract = {Objective: To explore Influencing factors of hospitalization costs in adult patients with bronchiectasis. Methods: The data were collected from public hospitals in China between May 2016 and December 2019, the information collected includes the following: total hospitalization cost, age, sex, blood routine, length of stay, and complications. Result: A total of 462 effective cases were collected in this study, including 234 males (50.65%) and 228 females (49.35%). In hospitalization costs, single total hospitalization cost is 13610.87 yuan per capita, among them the quartile is 7453.50 yuan, the median is 9893.51 yuan, upper quartile is 14153.62 yuan. Base on the proportion of hospitalization costs in adult patients with bronchiectasis, the drug cost was the highest (40.53%), the test cost was the second (20.59), and the nursing cost was the lowest (2.59%). In results of univariate analysis of cases with different characteristics, chronic obstructive pulmonary disease (COPD), smoking history, age, duration of hospitalization, and the percentage of neutrophils were statistical significance (p < 0.05). independent factors. Conclusion: independent factors of hospitalization costs in adult patients with bronchiectasis included hospitalization duration, smoking history, COPD, and high neutrophil percentage. Therefore, medical staffs should control and avoid those factors in treatment of adult patients with bronchiectasis.}, year = {2021} }
TY - JOUR T1 - Influencing Factors of Hospitalization Costs in Adult Patients with Bronchiectasis AU - Yanxiu Lei AU - Lineng Zhou AU - Yanli Yang AU - Ting Li Y1 - 2021/02/26 PY - 2021 N1 - https://doi.org/10.11648/j.ajns.20211001.26 DO - 10.11648/j.ajns.20211001.26 T2 - American Journal of Nursing Science JF - American Journal of Nursing Science JO - American Journal of Nursing Science SP - 86 EP - 90 PB - Science Publishing Group SN - 2328-5753 UR - https://doi.org/10.11648/j.ajns.20211001.26 AB - Objective: To explore Influencing factors of hospitalization costs in adult patients with bronchiectasis. Methods: The data were collected from public hospitals in China between May 2016 and December 2019, the information collected includes the following: total hospitalization cost, age, sex, blood routine, length of stay, and complications. Result: A total of 462 effective cases were collected in this study, including 234 males (50.65%) and 228 females (49.35%). In hospitalization costs, single total hospitalization cost is 13610.87 yuan per capita, among them the quartile is 7453.50 yuan, the median is 9893.51 yuan, upper quartile is 14153.62 yuan. Base on the proportion of hospitalization costs in adult patients with bronchiectasis, the drug cost was the highest (40.53%), the test cost was the second (20.59), and the nursing cost was the lowest (2.59%). In results of univariate analysis of cases with different characteristics, chronic obstructive pulmonary disease (COPD), smoking history, age, duration of hospitalization, and the percentage of neutrophils were statistical significance (p < 0.05). independent factors. Conclusion: independent factors of hospitalization costs in adult patients with bronchiectasis included hospitalization duration, smoking history, COPD, and high neutrophil percentage. Therefore, medical staffs should control and avoid those factors in treatment of adult patients with bronchiectasis. VL - 10 IS - 1 ER -